Menu
Type 1 diabetes is an autoimmune condition characterized by the destruction of insulin-producing beta cells in the pancreas. This results in insufficient insulin production, leading to elevated blood sugar levels and various complications. Traditional management primarily involves lifelong insulin therapy, which does not address the underlying cause of the disease.
Stem cell therapy presents a promising avenue for restoring insulin production by targeting and stimulating the regeneration of beta cells. Stem cells can differentiate into insulin-producing cells, potentially replenishing the lost beta cell population. Furthermore, these therapies may help modulate the immune response to prevent further destruction of the remaining healthy cells.
By enhancing beta cell function and insulin secretion, stem cell treatment has the potential to improve glycemic control, reduce the need for external insulin, and enhance the overall quality of life for individuals with Type 1 diabetes.
CRC specializes in treating autoimmune conditions with regenerative medicine to help modulate the immune system and reduce inflammation. Our doctors design personalized protocols to address the root causes of your condition, helping to manage symptoms and restore balance to your immune system. By targeting the body’s natural healing abilities, we aim to reduce flare-ups and improve your overall well-being, enabling you to regain control of your health.
Leading Stem Cells expert
One of the most prestigious specialists in Aesthetic procedures and Cosmetic Surgery in Tijuana, Mexico.
Owner of the ITC (Cell Therapy Institute), the biggest and most important Cell Banks in Mexico. He has treated Pro-Athletes and important politicians.
Dr. Cota has focused on regenerative medicine since 2021, with extensive experience in applying stem cells in clinical practice. Currently pursuing a Master’s in Regenerative Medicine, he is already contributing to patient treatment and outcomes. His background in Anesthesiology provides a deep understanding of pain management, further enhancing his impact on patient care.
Outcomes will vary between individuals. No claims are being made with regenerative therapies.
The FDA considers stem cell therapy experimental.
Links
Contact information
© 2024 Cellular Regeneration Clinic – All rights reserved.
